MediBeacon GFR monitor receives CE Mark

The MediBeacon Transdermal GFR Monitor and its reusable sensor have received the CE Mark under the European Medical Device Regulation. This certification signifies that the device meets the stringent safety and performance standards required for medical devices sold within the European Economic Area. The transdermal monitor offers a non-invasive method for assessing kidney function, potentially improving patient care and reducing healthcare burdens. This regulatory milestone is crucial for MediBeacon's market entry and commercialization efforts in Europe.